Jonathan Silverstein, Director, 10% Owner at Arcutis Biotherapeutics, Inc. (ARQT), bought 988,674 shares at $17.00 ($9.5M) on 2020-02-03, disclosed to the SEC on 2020-02-04.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.00 | 176,500 | $3.0M | 31.6% |
| 2 | $17.00 | 382,388 | $6.5M | 68.4% |
| 3 | $0.00 | 429,786 | $0 | 0.0% |
| Total | $9.61 avg | 988,674 | $9.5M | 100% |
| Filing → |
| TORC | BUY | 2018-01-30 | $8.0M | — | Filing → |
| GKOS | SELL | 2017-09-05 | $22.5M | — | Filing → |
| GKOS | SELL | 2017-08-17 | $16.0M | — | Filing → |